Johnson & Johnson Vision on track for multinational launch of newest contact lenses

Article

The company has received the all-clear for a multinational market launch of Acuvue Oasys Max 1-Day and Acuvue Oasys Max 1-Day multifocal contact lenses.

Johnson Johnson & Johnson Vision on track for multinational launch of newest contact lenses


Johnson & Johnson Vision announced Wednesday that it has received clearance from the US Food and Drug Administration (FDA), approval from Health Canada, and completed CE Mark activities for the Acuvue Oasys Max 1-Day and Acuvue Oasys Max 1-Day multifocal contact lenses.

The news comes during this year’s annual AOA Congress and AOSA conference: Optometry’s Meeting, in Chicago.

The new contact lenses were created to provide wearers with all day comfort and visual clarity, according to a news release. They are available in both spherical and multifocal lenses, and are designed to address numerous vision correction needs.

The release also referenced a recent survey that found that 71% of eye care professionals (ECPs) are seeing patients who are experiencing eye discomfort related to increased screentime. Further, younger patients wearing contact lenses are spending, on average, 9 hours a day in front of a screen—resulting in less blinking and more dryness and eye fatigue.

The lenses are expected to be available for wear in the US, Canada, and multiple European countries by fall, the release stated.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, outlines her AOA's Optometry's Meeting 2025 presentation on nutrition and its impact on ocular health.
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD; and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
© 2025 MJH Life Sciences

All rights reserved.